Protein C Inhibitor
Showing 1 - 25 of >10,000
Hemophilia B With Inhibitor, Hemophilia B Trial (SerpinPC)
Not yet recruiting
- Hemophilia B With Inhibitor
- Hemophilia B
- (no location specified)
Mar 16, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Lung Cancer Trial in Carlsbad, Cleveland (ISIS 3521, carboplatin, paclitaxel)
Completed
- Lung Cancer
- ISIS 3521
- +2 more
-
Carlsbad, California
- +1 more
Dec 1, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate
Not yet recruiting
- Cancer of Cervix
- Apoptosis
- Immunohistochemistry
- (no location specified)
Nov 17, 2023
Esophageal Achalasia Trial in Marseille, Montpellier, Nîmes (Protein pump inhibitor therapy systematically)
Recruiting
- Esophageal Achalasia
- Protein pump inhibitor therapy systematically
-
Marseille, France
- +3 more
Jun 2, 2023
Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)
Recruiting
- Hepatitis B, Chronic
- JNJ-73763989
- +4 more
-
Vancouver, British Columbia, Canada
- +31 more
Jan 17, 2023
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
C Reactive Protein and Its Correlation With Fetal Ultrasound
Recruiting
- Threatened Miscarriage
- Serum C reactive protein (CRP) level
- Ultrasound
-
Cairo, EgyptAl-Hussein University Hospital
Aug 23, 2023
Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)
Recruiting
- Lupus Nephritis
- 68Ga-FAPI-04 PET
-
Shanghai, ChinaRuijin Hospital
May 4, 2023
Diagnostic Importance of C-reactive Protein From Blood and
Not yet recruiting
- Acute Appendicitis
- Blood specimen collection for C-reactive protein (CRP) and WBC (white blood cells). Saliva specimen collection for analysis of CRP levels
- (no location specified)
Sep 20, 2023
Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)
Completed
- Fallopian Tube Carcinoma
- +2 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2021
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin
Not yet recruiting
- Juvenile Idiopathic Arthritis
- fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
- (no location specified)
Aug 29, 2023
Novel Antidiabetic Drug Combined With Angiotensin
Recruiting
- Type 2 Diabetes
- Antidiabetic Drugs
-
Beijing, Beijing, China
- +1 more
Jun 20, 2023
Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)
Not yet recruiting
- Metastatic Colorectal Cancer
- (no location specified)
Oct 31, 2023
High Sensitivity C Reactive Protein and Total Leucocytic Count
Not yet recruiting
- Abortion Early
- maternal serum C reactive protein
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Fibroblast Activation Protein Inhibitor PET/CT Imaging in
Recruiting
- Gastrointestinal Cancer
- Fibroblast activation protein inhibitor PET/CT imaging
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 14, 2022
C-Reactive Protein/Albumin Ratio and Acne Vulgaris
Completed
- Acne Vulgaris
- Biochemical blood analysis
-
Erzurum, TurkeyAtaturkU
Aug 21, 2023
Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)
Recruiting
- Healthy Adults
- Adagrasib
- Eltrombopag + adagrasib
-
Daytona Beach, FloridaFortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023
C-Reactive Protein /Albumin Ratio in Evaluation of Disease
Not yet recruiting
- Inflammatory Bowel Diseases
- CRP/Albumin ratio in IBD
- (no location specified)
Feb 21, 2023
Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))
Active, not recruiting
- Ovarian Neoplasms
- +2 more
- KU-0059436 (AZD2281)(PARP inhibitor)
-
Brussels, Belgium
- +4 more
Dec 19, 2022